The allure of wearable activity trackers has captured the attention of parents and health professionals alike. These devices promise to encourage physical activity in young people, but does the evidence support these claims? This systematic review and meta-analysis delves into the world of wearable trackers to assess their impact on daily steps and moderate-to-vigorous physical activity (MVPA) in children and adolescents. Our findings reveal insights into the effectiveness of these devices in promoting a healthier lifestyle for the next generation.
Physical inactivity is a growing concern among children and adolescents, contributing to a host of health issues. Wearable activity trackers have emerged as potential tools to combat this problem by providing real-time feedback on physical activity levels. While these devices have gained popularity, their efficacy in promoting sustained behavior change remains unclear. This study aims to systematically evaluate the evidence on the impact of wearable activity trackers on physical activity in young people.
We conducted a comprehensive search of four major databases for randomized controlled trials and clustered randomized controlled trials investigating the effects of wearable activity trackers on physical activity in children and adolescents. Data on participant characteristics, intervention details, and outcome measures were extracted and pooled using meta-analysis.
Our analysis included 21 studies involving over 3600 participants. While wearable activity trackers significantly increased daily step counts, their effect on MVPA was less pronounced. Heterogeneity between studies was evident, suggesting that factors such as intervention design, participant characteristics, and outcome measures influence the effectiveness of these devices.
The findings of this study indicate that wearable activity trackers can be a valuable tool for increasing daily steps in children and adolescents. However, their impact on MVPA, a crucial component of physical fitness, is less clear. Future research should explore the factors that contribute to the variability in study results and investigate the long-term effects of these devices.
Wearable activity trackers show promise in promoting physical activity among young people, particularly in terms of increasing daily step counts. However, their role in fostering sustained behavior change and improving overall health requires further investigation. To maximize the benefits of these devices, tailored interventions that combine wearable technology with other behavior change strategies may be necessary.
Au WW, Recchia F, Fong DY, et al. Effect of wearable activity trackers on physical activity in children and adolescents: a systematic review and meta-analysis. Lancet Digit Health. Published online August 6, 2024. doi:10.1016/S2589-7500(24)00139-0
1.
What is Mohs micrographic surgery? 8 FAQs about Mohs
2.
The Higher the Disability Burden From Disease, the Higher the Suicide Risk
3.
Older Men Increasingly Overtreated for Prostate Cancer, Study Suggests
4.
Anticoagulation for 12 months has been found to improve outcomes in cancer patients with minor blood clots.
5.
Addition of regional nodal irradiation does not decrease rates of invasive breast cancer recurrence, study finds
1.
Biomimetic Nanovesicles for Breast Cancer: Targeting Senescence to Overcome Chemoresistance
2.
Essential Oncology Updates: Diagnosis, Treatment Advances, Tools & Education Resources
3.
Enhancing Cancer Care: From Diagnosis Through Survivorship and Beyond
4.
Omentum Cancer: Causes, Symptoms, and Treatment Options
5.
Acrochordon: What It Is, Causes, And How To Manage This Skin Condition
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part IV
2.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part III
3.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part I
4.
The Landscape of First-Line Treatment for Urothelial Carcinoma- Further Discussion
5.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part II
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation